Synthesis and biological activity

Medicinal chemists working at the intersection of organic synthesis and biology design and build heterocyclic compounds—ring-shaped molecules containing atoms such as nitrogen or oxygen—and then test how those structures interact with biological targets like tubulin, the protein that cancer cells depend on to divide. Small structural changes to scaffolds such as chalcones, coumarins, and pyrazoles can dramatically shift a molecule's potency, selectivity, or toxicity profile, making the synthesis-activity relationship a central puzzle driving the work. A major open question is how to selectively disrupt tumor vasculature or block tubulin polymerization without harming healthy tissue, and researchers are actively exploring hybrid molecules that combine pharmacophores from two or more known scaffolds to achieve that balance. Understanding which molecular features govern the transition from a promising lab compound to a viable drug candidate remains one of the field's defining challenges.

Works

98,370

Total citations

910,541

Keywords

Heterocyclic CompoundsMedicinal ChemistryAnticancer AgentsTubulin InhibitorsVascular Targeting AgentsChalcones